drugset / Trial / NCT01827293

Promethazine vs. Lorazepam for Treatment of Vertigo

NCT01827293

Phase 3 Completed 210 enrolled Shahid Beheshti University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study was a prospective, randomized, double-blind, parallel group clinical trial designed to compare the efficacy of intravenous (IV) promethazine and lorazepam for the treatment of peripheral vertigo in Emergency Department setting.

Timeline

Start
2013-04
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lorazepam Small molecule 2 mg Intravenous
Comparator Promethazine Small molecule 25 mg Intravenous

Indications